Request Deal Involvement
Bristol-Myers Squibb completed the acquisition of MyoKardia for $13.1bn.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
pr advisors
W2O Group
financial advisors
Centerview Partners
legal advisors
Goodwin Procter
legal advisors to financial advisors
Sullivan & Cromwell
pr advisors
Precision AQ
financial advisors
Guggenheim Partners
financial advisors
Gordon Dyal & Co
financial advisors
Guggenheim Partners
legal advisors
Kirkland & Ellis
pr advisors
Joele Frank
legal advisors to financial advisors
Davis Polk & Wardwell
or
Principals
target
MYOKARDIA
bidder
BRISTOL MYERS SQUIBB COMPANY
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite